![]() |
|
![]() |
![]() Brooke MastersFinancial Times |
Streamlined testing smoothed the 737 Max’s path to market but speedy approvals generally harbinger scandals
Investors should not overlook the dreaded ‘stadium curse’
In the aftermath of #MeToo, companies are tightening their policies on office romances
Wells Fargo’s new CEO is about to get a taste of the perils of the lengthy commute
Lock up the stationery for the Christmas holidays and company managers risk real fury
It has taken a big bucket of ice water from profit-minded outsiders to cool the rental group’s backers
The industry does not have a good record when it comes to spotting early warning signs
These days, examiners are much less inclined to put lenders in a ‘penalty box’ to prevent them from growing
Companies worried about the expense of new regulations should remember that quality is key
Court cases targeting big pharma are just a taste of what is to come
Consolidation is sweeping through the sector
Big donations such as Oxford’s Schwarzman gift come with big dangers
Some big companies now see equal leave as a recruitment and retention tool
Well-developed legal systems are being used to bring global corporates to account
The likes of JPMorgan and BlackRock cannot ignore such concerns, but also have a duty to make money
Goldman Sachs’ David Solomon is far from the only boss to be hit by bad news after replacing a long-serving leader
The two disasters serve as a warning for industries, including self-driving cars where technology is taking over
But the episode undermines the CEO’s ability to pull the company out of a long scandal
US parents are going to ever greater lengths to secure places for their children
Multiple class structures have become increasingly popular in the tech sector
Companies say that accounting adjustments help investors, but there are dangers
An employee’s claim has cleared a legal hurdle and comes at a delicate time for the grocery chain
Prosecutors could yet conclude that the bank put business interests before compliance
One report proposes a UK body funded by an industry levy that would stand up for consumers
US auditors tightened controls but the British had no reason to do the same
Patients would probably have to keep taking the medication to maintain tolerance levels
Allegations about the bank’s dealings with 1MDB have the potential to cut deep
Nasdaq and the New York Stock Exchange have long profited as aggregators